Ashland Specialty Ingredients, a commercial unit of Ashland Inc., has completed a 13,000-square-foot expansion of its Macon, GA, facility and moved its Nuosept™ biocides production line to the new space.
The Dow Chemical Co.’s joint-venture membrane chlor-alkali facility, with Mitsui & Co. Ltd. of Tokyo, Japan (Mitsui), has successfully initiated full-scale, commercial production.
In order to meet growing customer demand, Oxea is planning to increase its European capacity for Oxsoft GPO (dioctyl terephthalate - DOTP) by 50,000 metric tons by the fourth quarter of 2015.
Axalta Coating Systems will begin the next phase of construction to significantly expand its waterborne production capacity at the company’s operations in Guarulhos, Brazil.
The chemical company Oxea has successfully increased its capacity by 20 percent for specialty esters at its Amsterdam Esters Plant (AEP) by implementing several optimization measures.
